Mesa Laboratories, Inc. (MLAB) financial statements and ratios from SEC XBRL: revenue $249.13M (TTM), net margin 2.7%, revenue growth 3.4% YoY, P/E 48.8. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $249.13M |
| Net Margin | 2.7% |
| Revenue Growth (YoY) | 3.4% |
| EPS Growth (YoY) | -438.9% |
| FCF Growth (YoY) | -7.0% |
| P/E Ratio | 48.8 |
| EV / EBITDA | 25.1 |
| Price / Book | 3.54 |
| Price / Sales | 2.72 |
| FCF Yield | 7.4% |
| DCF Value (model) | $6.22 |
| DCF Upside vs Price | -94.8% |
| Altman Z-Score | 1.88 (grey) |
| Piotroski F-Score | 8/9 |
| Sector P/E (Technology) | 33.9 |
MLAB overview · MLAB earnings · MLAB KPIs · MLAB investor relations · MLAB ownership · MLAB peers · MLAB filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.